News | EP Lab | April 07, 2021

Broward Health Medical Center First in Florida to Adopt Robotic Ablation Technology to Treat Arrhythmias

The Stereotaxis Genesis Robotic Magnetic Navigation system.

The Stereotaxis Genesis Robotic Magnetic Navigation system.

April 7, 2021 — Stereotaxis announced that Broward Health Medical Center is establishing a robotic electrophysiology (EP) program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida. Broward will be the only hospital in South Florida offering robotic technology to treat patients suffering from arrhythmias and is the first in Florida, and among the first in the nation, to adopt the latest Genesis Robotic Magnetic Navigation system.

“The adoption of this advanced robotic technology further reinforces the commitment Broward Health Medical Center has toward providing high quality cardiac care for patients suffering from all types of arrhythmias,” said Ahmed Osman, M.D., medical director of the cardiac electrophysiology lab. “This technology helps enhance the reach, precision and stability of the traditional tools used in ablation therapy, while having inherent attributes that can increase safety. We are very excited to have access to this technology for our patients.”

Stereotaxis robotic magnetic navigation introduces the benefits of robotic precision and safety to what are often long cardiac ablation procedures.

“On the heels of Broward Health Medical Center’s recent IAC accreditation for electrophysiology, we are excited to bring this latest technology to our complex arrhythmia program,” said Heather Havericak, CEO of Broward Health Medical Center. “Studies suggest that one in four Americans over the age of 40 could develop irregular heartbeats, and over 2.3 million Americans suffer from atrial fibrillation. The adoption of Robotic Magnetic Navigation supports our commitment to providing comprehensive cardiac care for our community and the greater tri-county area.”

“We are delighted to partner with Broward Health to help enhance quality of care and access to therapy for patients in Florida,” said David Fischel, chairman and CEO of Stereotaxis. “We applaud their leadership and look forward to supporting their efforts to build a preeminent heart rhythm program in the region.”

For more information: www.stereotaxis.com
 

Related EP Robotic Systems Content:

VIDEO: Virtual Tour of the Robotic Electrophysiology Lab at Banner Health — Interview with Peter Weiss, M.D.

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

VIDEO: Advantages of Robotic Ablation in the EP Lab — Interview with Peter Weiss, M.D.

Time to Take Another Look at Robotics in Electrophysiology — Article by Peter Weiss, M.D.

Stereotaxis and Acutus Medical Announce Strategic Collaboration
 

Find more news on robotic cath lab and EP lab systems

Related Content

The Acutus Medical AcQBlate Force sensing ablation catheter.

The Acutus Medical AcQBlate Force sensing ablation catheter.

News | Ablation Systems | April 05, 2021
April 5, 2021 — Acutus Medical today announced initial U.S.
The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Thermedical Durablate catheter to treat VT. #HRS20 #HRS2020 #heartrhythm2020
News | Ablation Systems | May 08, 2020
May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SER
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20

The Affera Inc. pulsed field (PF) energy radiofrequency ablation system.

Feature | Ablation Systems | May 08, 2020
May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or par
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically
Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...